603139 康惠制药
已收盘 08-26 15:00:00
资讯
新帖
简况
康惠制药08月26日主力资金流出73万元 连续7日减仓
市场透视 · 08-26 15:18
康惠制药08月26日主力资金流出73万元 连续7日减仓
康惠制药08月22日主力资金流出57万元 连续5日减仓
市场透视 · 08-22
康惠制药08月22日主力资金流出57万元 连续5日减仓
康惠制药： 公司目前不涉及人形机器人业务
证券之星 · 08-20
康惠制药： 公司目前不涉及人形机器人业务
康惠制药：博恩生物是公司的参股子公司，公司目前的持股比例为9.79%
每日经济新闻 · 08-20
康惠制药：博恩生物是公司的参股子公司，公司目前的持股比例为9.79%
康惠制药：公司七味天麻药酒的辅料白酒不是公司自行生产的，是外部购入的
每日经济新闻 · 08-20
康惠制药：公司七味天麻药酒的辅料白酒不是公司自行生产的，是外部购入的
康惠制药08月20日主力资金流出193万元 连续3日减仓
自选股智能写手 · 08-20
康惠制药08月20日主力资金流出193万元 连续3日减仓
肝炎概念盘中跳水，康惠制药跌0.08%
自选股智能写手 · 08-20
肝炎概念盘中跳水，康惠制药跌0.08%
冯越峰操纵“康惠制药”等3股获利145万 被证监会罚没超580万元
格隆汇 · 08-16
冯越峰操纵“康惠制药”等3股获利145万 被证监会罚没超580万元
8月14日康惠制药（603139）龙虎榜数据：游资章盟主、上塘路上榜
证券之星 · 08-14
8月14日康惠制药（603139）龙虎榜数据：游资章盟主、上塘路上榜
龙虎榜|康惠制药下跌7.61%，财通证券杭州上塘路席位卖出1369.06万元
自选股智能写手 · 08-14
龙虎榜|康惠制药下跌7.61%，财通证券杭州上塘路席位卖出1369.06万元
IPO梦碎后拟借壳康惠制药？恒昌医药意向金屡“打水漂”，陷合同纠纷漩涡
市场资讯 · 08-14
IPO梦碎后拟借壳康惠制药？恒昌医药意向金屡“打水漂”，陷合同纠纷漩涡
康惠制药大跌5% 获主力净流入161万元
智选洞察 · 08-14
康惠制药大跌5% 获主力净流入161万元
21健讯Daily | 国家药监局通报37批次不符合规定化妆品；康惠制药回应借“壳”上市传言
21财经网 · 08-14
21健讯Daily | 国家药监局通报37批次不符合规定化妆品；康惠制药回应借“壳”上市传言
康惠制药最新公告：新建生产基地通过药品GMP符合性检查
证券之星 · 08-13
康惠制药最新公告：新建生产基地通过药品GMP符合性检查
康惠制药(603139.SH)：新建生产基地通过药品GMP符合性检查
智通财经网 · 08-13
康惠制药(603139.SH)：新建生产基地通过药品GMP符合性检查
恒昌医药控股股东或将成为公司第二大股东，康惠制药回应借“壳”上市
红星资本局 · 08-13
恒昌医药控股股东或将成为公司第二大股东，康惠制药回应借“壳”上市
恒昌医药将借壳康惠制药？康惠制药回应
中国金融信息网 · 08-13
恒昌医药将借壳康惠制药？康惠制药回应
康惠制药（603139）8月13日主力资金净卖出1302.14万元
证券之星 · 08-13
康惠制药（603139）8月13日主力资金净卖出1302.14万元
【恒昌医药控股股东将成公司二股东 康惠制药回应借“壳”上市传言】金十数据8月13日讯，康惠制药早盘跌停。消息面上，近期，康惠制药公告，公司股东TBP拟将10%公司股份转让给恒昌医药控股股东上海赛乐仙企业管理咨询有限公司，若转让完成，赛乐仙将成为康惠制药二股东。
美港电讯 · 08-13
【恒昌医药控股股东将成公司二股东 康惠制药回应借“壳”上市传言】金十数据8月13日讯，康惠制药早盘跌停。消息面上，近期，康惠制药公告，公司股东TBP拟将10%公司股份转让给恒昌医药控股股东上海赛乐仙企业管理咨询有限公司，若转让完成，赛乐仙将成为康惠制药二股东。
恒昌医药控股股东将成公司二股东，康惠制药回应借“壳”上市传言
21世纪经济报道 · 08-13
恒昌医药控股股东将成公司二股东，康惠制药回应借“壳”上市传言
暂无数据
公司概况
公司名称：
陕西康惠制药股份有限公司
所属行业：
医药制造业
上市日期：
2017-04-21
主营业务：
陕西康惠制药股份有限公司主营业务为中成药品的研究、开发、生产与销售，公司主要产品为消银颗粒、复方双花片、坤复康胶囊（片）、附桂骨痛胶囊、复方清带灌注液、骨刺胶囊、熊胆痔疮膏等。公司的“万花山及图”商标被原国家工商行政管理总局商标局认定为中国驰名商标，并多次被评为陕西省著名商标；公司被国家知识产权局评为“国家知识产权优势企业”、“国家知识产权示范企业”。
发行价格：
14.57
{"stockData":{"symbol":"603139","market":"SH","secType":"STK","nameCN":"康惠制药","latestPrice":11.49,"timestamp":1724655600000,"preClose":11.26,"halted":0,"volume":1351700,"delay":0,"floatShares":99880000,"shares":99880000,"eps":-0.3332,"marketStatus":"已收盘","marketStatusCode":5,"change":0.23,"latestTime":"08-26 15:00:00","open":11.3,"high":11.6,"low":11.21,"amount":15487000,"amplitude":0.0346,"askPrice":11.5,"askSize":51,"bidPrice":11.49,"bidSize":9,"shortable":0,"etf":0,"ttmEps":-0.3332,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724722200000},"adr":0,"adjPreClose":11.26,"symbolType":"stock","openAndCloseTimeList":[[1724635800000,1724643000000],[1724648400000,1724655600000]],"highLimit":12.39,"lowLimit":10.13,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":99880000,"pbRate":1.21,"roa":"--","roe":"0.11%","epsLYR":-0.26,"committee":-0.228346,"marketValue":1148000000,"floatMarketCap":1148000000,"peRate":-34.483793,"changeRate":0.0204,"turnoverRate":0.0135,"status":0},"requestUrl":"/m/hq/s/603139/tweets","defaultTab":"tweets","newsList":[{"id":"2462954787","title":"康惠制药08月26日主力资金流出73万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2462954787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462954787?lang=zh_cn&edition=full","pubTime":"2024-08-26 15:18","pubTimestamp":1724656739,"startTime":"0","endTime":"0","summary":"08月26日, 康惠制药股价涨2.04%，报收11.49元，成交金额1548万元，换手率1.35%，振幅3.46%，量比0.76。康惠制药今日主力资金净流出73万元，连续7日净流出，上一交易日主力净流出47万元，今日环比增加55.32%。该股近5个交易日下跌3.61%，主力资金累计净流出398万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1345万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408261535149f59adb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408261535149f59adb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2461836165","title":"康惠制药08月22日主力资金流出57万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2461836165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461836165?lang=zh_cn&edition=full","pubTime":"2024-08-22 15:19","pubTimestamp":1724311178,"startTime":"0","endTime":"0","summary":"08月22日, 康惠制药股价跌1.03%，报收11.51元，成交金额1414万元，换手率1.22%，振幅3.27%，量比0.41。康惠制药今日主力资金净流出57万元，连续5日净流出，上一交易日主力净流出31万元，今日环比增加83.87%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为57.14%，平均跌幅为1.36%。该股近5个交易日下跌6.12%，主力资金累计净流出771万元；近20日主力资金累计净流出1191万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408221551029f46fc96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408221551029f46fc96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2460007511","title":"康惠制药：\n公司目前不涉及人形机器人业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2460007511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460007511?lang=zh_cn&edition=full","pubTime":"2024-08-20 18:04","pubTimestamp":1724148263,"startTime":"0","endTime":"0","summary":"后续若有相关进展，公司将即时履行信息披露义务。公司目前不涉及人形机器人业务。男春宝胶囊为公司系列产品之一，公司根据市场销售情况及库存情况合理安排生产任务，该产品没有停产。公司目前暂无治疗痘病毒相关药物。博恩生物是公司的参股子公司，公司目前的持股比例为9.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000030447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300024","603139","BK0028","BK0130","BK0196","BK0005","159526","BK0073","BK0061","BK0188","BK0089","BK0239","BK0259","BK0122"],"gpt_icon":0},{"id":"2460794020","title":"康惠制药：博恩生物是公司的参股子公司，公司目前的持股比例为9.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460794020","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460794020?lang=zh_cn&edition=full","pubTime":"2024-08-20 17:01","pubTimestamp":1724144482,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问贵公司投资的西安博恩生物科技有限公司有没有涉及同种异体骨材料？该公司的骨材料是怎么来的？康惠制药（603139.SH）8月20日在投资者互动平台表示，博恩生物是公司的参股子公司，公司目前的持股比例为9.79%。博恩生物不涉及同种异体骨材料的问题，博恩生物研发使用的材料是羟基磷灰石（HA）是化学合成的无机盐材料，不是从动物或者人体取得的材料。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082017015295aa2462&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082017015295aa2462&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2460202258","title":"康惠制药：公司七味天麻药酒的辅料白酒不是公司自行生产的，是外部购入的","url":"https://stock-news.laohu8.com/highlight/detail?id=2460202258","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460202258?lang=zh_cn&edition=full","pubTime":"2024-08-20 16:58","pubTimestamp":1724144313,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：公司产品七味天麻药酒的辅料白酒是公司自行生产的吗？康惠制药（603139.SH）8月20日在投资者互动平台表示，公司七味天麻药酒的辅料白酒不是公司自行生产的，是外部购入的。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201659029f3d4780&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201659029f3d4780&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2460312025","title":"康惠制药08月20日主力资金流出193万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2460312025","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460312025?lang=zh_cn&edition=full","pubTime":"2024-08-20 15:19","pubTimestamp":1724138357,"startTime":"0","endTime":"0","summary":"08月20日, 康惠制药股价跌1.85%，报收11.70元，成交金额2283万元，换手率1.94%，振幅2.94%，量比0.42。康惠制药今日主力资金净流出193万元，连续3日净流出，上一交易日主力净流出332万元，今日环比减少41.87%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为55.56%，平均跌幅为1.24%。该股近5个交易日下跌12.75%，主力资金累计净流出2336万元；近20日主力资金累计净流出1126万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201539569f3ce329&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201539569f3ce329&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2460019494","title":"肝炎概念盘中跳水，康惠制药跌0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460019494","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460019494?lang=zh_cn&edition=full","pubTime":"2024-08-20 10:13","pubTimestamp":1724120018,"startTime":"0","endTime":"0","summary":"08月20日，肝炎概念盘中跳水，截至10点13分，肝炎概念整体指数下跌1.01%，报771.690点。从个股上来看，该概念的成分股中，康惠制药跌0.08%，之江生物跌幅居前。从资金上来看，截止发稿，肝炎概念概念主力净流入为-1646.00万，其中达安基因受到资金热捧，主力净流入6260.28万；拉长时间线来看，该板块近20日主力资金净流入-23.69亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820101338aefedb90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820101338aefedb90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2459129960","title":"冯越峰操纵“康惠制药”等3股获利145万 被证监会罚没超580万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459129960","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459129960?lang=zh_cn&edition=full","pubTime":"2024-08-16 17:53","pubTimestamp":1723802019,"startTime":"0","endTime":"0","summary":"格隆汇8月16日｜中国证监会发布行政处罚决定书（冯越峰），2017年6月26日至2018年7月2日期间，冯越峰控制使用账户组操纵“康惠制药”“康盛股份”“柯利达”等3只股票交易价格和交易量，合计获利1,454,511.85元。证监会决定：没收冯越峰违法所得1,454,511.85元，并处以4,363,535.55元的罚款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408161754019f30d802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408161754019f30d802&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2459142600","title":"8月14日康惠制药（603139）龙虎榜数据：游资章盟主、上塘路上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2459142600","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459142600?lang=zh_cn&edition=full","pubTime":"2024-08-14 17:12","pubTimestamp":1723626776,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2024年8月14日公布的交易公开信息显示，康惠制药因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2024年8月14日收盘，康惠制药报收于12.39元，下跌7.61%，换手率9.0%，成交量8.99万手，成交额1.13亿元。从龙虎榜公布的当日买卖数据来看，章盟主、上塘路等知名游资榜上有名。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400036847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2459417811","title":"龙虎榜|康惠制药下跌7.61%，财通证券杭州上塘路席位卖出1369.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459417811","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459417811?lang=zh_cn&edition=full","pubTime":"2024-08-14 17:00","pubTimestamp":1723626021,"startTime":"0","endTime":"0","summary":"8月14日，康惠制药下跌7.61%，龙虎榜数据显示，当日上榜营业部全天成交3960.72万元，占当日总成交金额比例为35.06%。其中，买入金额为763.39万元，卖出金额为3197.33万元，合计净卖出2433.94万元。此外中信证券上海分公司、国泰君安证券上海江苏路营业部分别买入258.77万元、159.84万元；财通证券杭州上塘路、联储证券浙江分公司营业部分别卖出1369.06万元、832.84万元；值得注意的是，这也是康惠制药在30日内第3次上榜龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408141700319597deab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408141700319597deab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601108","BK0276","BK0239","603139"],"gpt_icon":0},{"id":"2459195821","title":"IPO梦碎后拟借壳康惠制药？恒昌医药意向金屡“打水漂”，陷合同纠纷漩涡","url":"https://stock-news.laohu8.com/highlight/detail?id=2459195821","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459195821?lang=zh_cn&edition=full","pubTime":"2024-08-14 14:00","pubTimestamp":1723615200,"startTime":"0","endTime":"0","summary":"股价涨近8%后10CM跌停，康惠制药（维权）近日二级市场可谓是“跌宕起伏”。8月14日，康惠制药再度低开，截至发稿股价报12.57元/股，跌幅为6.26%，总市值为12.55亿元。 上述股份受让方赛乐仙为湖南恒昌医药集团股份有限公司控股股东。公开资料显示，截至2023年上半年末，赛乐仙咨询直接持有恒昌医药2.22亿股，占总股本的61.57%。 恒昌医药曾于2022年申报创业板上市，此后历经三次问询，最终于2024年7月2日主动撤单。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/chanjing/gsnews/2024-08-14/doc-inciqxcn4440508.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/chanjing/gsnews/2024-08-14/doc-inciqxcn4440508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","09939","603139","BK0239","159938","BK1574","BK1515"],"gpt_icon":0},{"id":"2459466161","title":"康惠制药大跌5% 获主力净流入161万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459466161","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459466161?lang=zh_cn&edition=full","pubTime":"2024-08-14 09:31","pubTimestamp":1723599067,"startTime":"0","endTime":"0","summary":"08月14日，康惠制药股价大幅下跌，截至09点31分，康惠制药下跌5.00%，报12.74元/股，成交1007万元，换手率0.79%，振幅1.79%。资金动向截止发稿，康惠制药获得主力净流入161万元，其中超大单流入106万元，大单流入54万元。此外，康惠制药08月13日上榜龙虎榜。最新财报显示，今年一季报，康惠制药实现营业收入1.27亿元，同比增长2.89%，净利润为108.63万元，同比减少86.76%，基本每股收益为0.01元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814093123a1d4399b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814093123a1d4399b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2459168883","title":"21健讯Daily | 国家药监局通报37批次不符合规定化妆品；康惠制药回应借“壳”上市传言","url":"https://stock-news.laohu8.com/highlight/detail?id=2459168883","media":"21财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459168883?lang=zh_cn&edition=full","pubTime":"2024-08-14 07:45","pubTimestamp":1723592743,"startTime":"0","endTime":"0","summary":"政策动向国家药监局通报37批次不符合规定化妆品8月13日，国家药监局发布消息，在2023年国家化妆品抽样检验工作中，经海南省药品检验所等单位检验，产品标签标示为广州汉方化妆品制造有限公司生产的韩秀宫雪莲草本修护膜等37批次化妆品不符合规定。国家药监局此次通报有助于净化市场环境，维护消费者权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408140745489f28a303&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408140745489f28a303&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2459922486","title":"康惠制药最新公告：新建生产基地通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2459922486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459922486?lang=zh_cn&edition=full","pubTime":"2024-08-13 17:39","pubTimestamp":1723541971,"startTime":"0","endTime":"0","summary":"康惠制药公告，新建的位于咸阳市秦都区胭脂路36号的生产基地通过药品生产质量管理规范符合性检查（简称“药品GMP符合性检查”），并取得陕西省药品监督管理局颁发的《药品生产许可证》。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300035596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2459247949","title":"康惠制药(603139.SH)：新建生产基地通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2459247949","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459247949?lang=zh_cn&edition=full","pubTime":"2024-08-13 17:31","pubTimestamp":1723541516,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康惠制药(603139.SH)公告，近日，公司新建的位于咸阳市秦都区胭脂路36号的生产基地通过药品生产质量管理规范符合性检查(“药品GMP符合性检查”)，并取得陕西省药品监督管理局颁发的《药品生产许可证》。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1163540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","603139"],"gpt_icon":0},{"id":"2459234659","title":"恒昌医药控股股东或将成为公司第二大股东，康惠制药回应借“壳”上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2459234659","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459234659?lang=zh_cn&edition=full","pubTime":"2024-08-13 16:24","pubTimestamp":1723537440,"startTime":"0","endTime":"0","summary":"近期，有传言称，刚刚终止上市的湖南恒昌医药集团股份有限公司有可能借“壳”康惠制药。本次权益变动前，TBP持有康惠制药14.81%股份，赛乐仙未持有其股份。若转让完成，赛乐仙将成为康惠制药二股东。天眼查显示，在7月份终止IPO的恒昌医药的控股股东正是赛乐仙，赛乐仙持股约61.7%。7月，康惠制药公布2024年半年度业绩预告，预计今年上半年实现归属于母公司所有者的净利润为-1000万元到-700万元，将出现亏损。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/cj/2024-08-13/doc-incinueh0357721.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2024-08-13/doc-incinueh0357721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603139","159938","09939","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2459947596","title":"恒昌医药将借壳康惠制药？康惠制药回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2459947596","media":"中国金融信息网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459947596?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:23","pubTimestamp":1723533780,"startTime":"0","endTime":"0","summary":"有消息称，恒昌医药将借壳康惠制药上市。对此，康惠制药证券部工作人员回应记者称，恒昌医药是赛乐仙的子公司，赛乐仙前段时间拟通过协议转让购买公司二股东的股权。本次权益变动后，TBP持有公司股份480.41万股，占公司总股本的4.8099%。本次权益变动前，赛乐仙未持有公司股份，本次权益变动后，赛乐仙持有公司股份998.8万股，占公司总股本的10%，成为公司持股5%以上股东。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-08-13/doc-incinuek8602886.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-08-13/doc-incinuek8602886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603139","BK1574","09939","BK1515","BK1161","159938","BK0239"],"gpt_icon":0},{"id":"2459942867","title":"康惠制药（603139）8月13日主力资金净卖出1302.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459942867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459942867?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:14","pubTimestamp":1723533256,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月13日收盘，康惠制药报收于13.41元，下跌10.0%，跌停，换手率2.78%，成交量2.77万手，成交额3720.08万元。康惠制药主营业务：以中成药品的研究、生产、销售为主,以生物制品(除疫苗)、血液制品、药品的销售配送业务为辅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300024844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603139","BK0239"],"gpt_icon":0},{"id":"2459916497","title":"【恒昌医药控股股东将成公司二股东 康惠制药回应借“壳”上市传言】金十数据8月13日讯，康惠制药早盘跌停。消息面上，近期，康惠制药公告，公司股东TBP拟将10%公司股份转让给恒昌医药控股股东上海赛乐仙企业管理咨询有限公司，若转让完成，赛乐仙将成为康惠制药二股东。","url":"https://stock-news.laohu8.com/highlight/detail?id=2459916497","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459916497?lang=zh_cn&edition=full","pubTime":"2024-08-13 11:51","pubTimestamp":1723521107,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1161","BK0239","BK1515","BK1574","159938","09939","603139"],"gpt_icon":0},{"id":"2459521915","title":"恒昌医药控股股东将成公司二股东，康惠制药回应借“壳”上市传言","url":"https://stock-news.laohu8.com/highlight/detail?id=2459521915","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459521915?lang=zh_cn&edition=full","pubTime":"2024-08-13 11:25","pubTimestamp":1723519500,"startTime":"0","endTime":"0","summary":"南方财经8月13日电，康惠制药早盘跌停。消息面上近期，康惠制药公告，公司股东TBP拟将10%公司股份转让给恒昌医药控股股东上海赛乐仙企业管理咨询有限公司，若转让完成，赛乐仙将成为康惠制药二股东。南方财经全媒体记者以投资人身份联系了康惠制药投资者关系部门，对于跌停，相关人士称，“我们也不是很清楚，都是市场行为”。对于不少投资人猜测，恒昌医药有可能借康惠制药“壳”上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408131126259f260905&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408131126259f260905&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603139","159938","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-04-21","address":"陕西省咸阳市秦都区高新技术开发区彩虹二路","stockEarnings":[{"period":"1week","weight":-0.0361},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.1781},{"period":"6month","weight":-0.0704},{"period":"1year","weight":-0.3257},{"period":"ytd","weight":-0.3879}],"companyName":"陕西康惠制药股份有限公司","boardCode":"AI0027","perCapita":"9261股","boardName":"医药制造业","registeredCapital":"9988万元","compareEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":-0.0122},{"period":"3month","weight":-0.0817},{"period":"6month","weight":-0.0346},{"period":"1year","weight":-0.0681},{"period":"ytd","weight":-0.0401}],"survey":" 陕西康惠制药股份有限公司主营业务为中成药品的研究、开发、生产与销售，公司主要产品为消银颗粒、复方双花片、坤复康胶囊（片）、附桂骨痛胶囊、复方清带灌注液、骨刺胶囊、熊胆痔疮膏等。公司的“万花山及图”商标被原国家工商行政管理总局商标局认定为中国驰名商标，并多次被评为陕西省著名商标；公司被国家知识产权局评为“国家知识产权优势企业”、“国家知识产权示范企业”。","serverTime":1724696135117,"listedPrice":14.57,"stockholders":"10784人(较上一季度增加10.53%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康惠制药(603139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康惠制药(603139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康惠制药,603139,康惠制药股票,康惠制药股票老虎,康惠制药股票老虎国际,康惠制药行情,康惠制药股票行情,康惠制药股价,康惠制药股市,康惠制药股票价格,康惠制药股票交易,康惠制药股票购买,康惠制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康惠制药(603139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康惠制药(603139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}